Trade

with

ICU Medical Inc
(NASDAQ: ICUI)
AdChoices
69.92
+0.13
+0.19%
After Hours :
69.92
0.00
0.00%

Open

69.15

Previous Close

69.79

Volume (Avg)

49.01k (105.63k)

Day's Range

69.15-70.91

52Wk Range

54.00-70.98

Market Cap.

1.07B

Dividend Rate ( Yield )

-

Beta

0.57

Shares Outstanding

15.27M

P/E Ratio (EPS)

29.15 (2.39)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Medical Instruments & Supplies
Highlights
Analyst Recommendation: Hold
    • Revenue

    • 313.72M

    • Net Income

    • 40.42M

    • Market Cap.

    • 1.07B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 11.80

    • PEG (Price/Earnings Growth) Ratio

    • 1.94

    • Beta

    • 0.57

    • Forward P/E

    • 19.31

    • Price/Sales

    • 3.45

    • Price/Book Value

    • 2.20

    • Price/Cash flow

    • 15.67

      • EBITDA

      • 71.46M

      • Return on Capital %

      • 7.60

      • Return on Equity %

      • 8.20

      • Return on Assets %

      • 7.60

      • Book Value/Share

      • 31.79

      • Shares Outstanding

      • 15.27M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Hold
        • 1 Year Price Target

        • 56.00

        • Credit Rating

        • -

        • Analysts

        • 1

        • EPS Estimate

        • -

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 0.00

          • 10.42

          • Net Income

            YTD/YTD (last year)

          • -2.10

          • -15.59

          • Net Income

            Q/Q (last year)

          • -20.20

          • -8.93

          • Sales (Revenue)

            5-Year Annual Average

          • 8.91

          • 12.51

          • Net Income

            5-Year Annual Average

          • 10.70

          • 4.16

          • Dividends

            5-Year Annual Average

          • -

          • 0.97

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 49.08

            • 52.83

            • Pre-Tax Margin

            • 15.46

            • 15.96

            • Net Profit Margin

            • 11.80

            • 12.40

            • Average Gross Margin

              5-Year Annual Average

            • 47.70

            • 52.66

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 18.50

            • 18.40

            • Average Net Profit Margin

              5-Year Annual Average

            • 12.60

            • 93.46B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.62

              • Current Ratio

              • 15.21

              • 1.97

              • Quick Ratio

              • 13.16

              • 1.16

              • Interest Coverage

              • -

              • 10.47

              • Leverage Ratio

              • 1.07

              • 2.38

              • Book Value/Share

              • 31.79

              • 12.15

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 29.33

                • 36.10

                • P/E Ratio 5-Year High

                • 35.52

                • 279.08

                • P/E Ratio 5-Year Low

                • 12.77

                • 148.87

                • Price/Sales Ratio

                • 3.46

                • 3.37

                • Price/Book Value

                • 2.21

                • 4.21

                • Price/Cash Flow Ratio

                • 15.67

                • 17.42

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • 8.20

                    (11.60)

                  • 17.93

                    (21.42)

                  • Return on Assets %

                    (5-Year Average)

                  • 7.60

                    (10.30)

                  • 7.35

                    (9.50)

                  • Return on Capital %

                    (5-Year Average)

                  • 8.20

                    (11.60)

                  • 10.24

                    (13.59)

                  • Income/Employee

                  • 16.26k

                  • 25.65k

                  • Inventory Turnover

                  • 4.30

                  • 2.66

                  • Asset Turnover

                  • 0.64

                  • 0.59

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  51.95M
                  Operating Margin
                  16.56
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  15.67
                  Ownership

                  Institutional Ownership

                  96.92%

                  Top 10 Institutions

                  47.71%

                  Mutual Fund Ownership

                  49.07%

                  Float

                  78.18%

                  5% / Insider Ownership

                  4.03%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Champlain - Small Cap Equity

                  •  

                    626,120

                  • -1.95

                  • 4.10

                  • GAM North American Growth

                  •  

                    450,000

                  • 0.00

                  • 2.95

                  • Victory Small Company Opportunity Fund

                  •  

                    348,200

                  • 11.57

                  • 2.28

                  • iShares Core S&P Small-Cap (AU)

                  •  

                    272,192

                  • 0.20

                  • 1.94

                  • Vanguard Small Cap Index

                  •  

                    238,891

                  • 0.18

                  • 1.56

                  • JHVIT Small Cap Value Trust

                  •  

                    232,610

                  • -1.70

                  • 1.52

                  • Champlain Small Company Fund

                  •  

                    230,000

                  • 4.55

                  • 1.51

                  • Vanguard Total Stock Mkt Idx

                  •  

                    224,005

                  • 0.65

                  • 1.47

                  • iShares Russell 2000 (AU)

                  •  

                    200,119

                  • -1.47

                  • 1.43

                  • USAA Small Cap Stock Fund

                  •  

                    174,500

                  • 0.00

                  • 1.14

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Wellington Management Company, LLP

                  •  

                    1,769,001

                  • +4.68%

                  • 11.59

                  • Vanguard Group, Inc.

                  •  

                    912,978

                  • +1.30%

                  • 5.98

                  • BlackRock Fund Advisors

                  •  

                    688,965

                  • -4.86%

                  • 4.51

                  • Champlain Investment Partners, LLC

                  •  

                    686,720

                  • +1.14%

                  • 4.50

                  • Renaissance Technologies Corp

                  •  

                    645,500

                  • -11.84%

                  • 4.23

                  • Boston Trust & Investment Management Co.

                  •  

                    577,104

                  • -1.67%

                  • 3.78

                  • Gannett Welsh & Kotler, LLC

                  •  

                    567,460

                  • +1.10%

                  • 3.72

                  • Dimensional Fund Advisors, Inc.

                  •  

                    491,330

                  • +13.65%

                  • 3.22

                  • Silvercrest Asset Management Group LLC

                  •  

                    488,740

                  • +17.37%

                  • 3.20

                  • GAM London Limited

                  •  

                    454,600

                  • +28.96%

                  • 2.98

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Medical Instruments & Supplies

                  Type

                  Classic Growth

                  Style

                  Small Core

                  ICU Medical, Inc. is a Delaware Corporation founded in 1984 and its initial public offering was in 1992. The Company is engaged in the development, manufacture and sale of innovative medical devices used in infusion therapy, oncology...more and critical care applications. Its products improve patient outcomes by helping to prevent bloodstream infections and protect healthcare workers and patients from exposure to infectious diseases or hazardous drugs and monitoring continuous cardiac output of critical care patients. The Company’s complete product line includes custom infusion systems, closed delivery systems for hazardous drugs, needle free infusion connectors, catheters and cardiac monitoring systems. Its products are categorized into three main product lines: Infusion Therapy, Critical Care and Oncolog...morey. I.V. therapy lines, used in hospitals and ambulatory clinics, consist of a tube running from a bottle or plastic bag containing an I.V. solution to a catheter inserted in a patient’s vein. The tube typically has several injection ports or Y-sites (conventionally, entry tubes covered by rubber caps) to which a secondary I.V. line can be connected to permit constant intravenous administration of medications, fluids and nutrients, and to allow instantaneous intravenous administration of emergency medication. Critical care products are used to monitor vital signs as well as specific physiological functions of key organ systems and Oncology: Oncology products are used to prepare and deliver hazardous medications such as those used in chemotherapy which, if released, can have harmful effects to the healthcare worker and environment. Manufacturing of its products involves injection molding of plastic and silicone parts, manual and automated assembly of the molded plastic parts, needles and other components, quality control inspection, packaging and sterilization. The Company currently sells all of its products to I.V. product manufacturers, independent distributors and direct sales to the end user. It competes with other manufacturers of closed system transfer devices for the safe handling of oncology drugs, notably Becton Dickinson, CareFusion and B Braun. The Company’s products are subject to clearance by the United States Food and Drug Administration (“FDA”) under a number of statutes including the Food Drug and Cosmetics Act (“FDC Act”).lessless

                  Key People

                  Mr. Vivek Jain

                  CEO/Chairman of the Board/Director

                  Mr. Scott E. Lamb

                  CFO/ Secretary/Treasurer

                  Mr. Steven C. Riggs

                  Vice President, Divisional

                  Ms. Alison D. Burcar

                  Vice President, Divisional

                  Dr. George A. Lopez,M.D.

                  Director

                  • ICU Medical Inc

                  • 951 Calle Amanecer

                  • San Clemente, CA 92673

                  • USA.Map

                  • Phone: +1 949 366-2183

                  • Fax: +1 949 366-8368

                  • icumed.com

                  Incorporated

                  1984

                  Employees

                  2,269

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: